# A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso

> **NCT00452088** · PHASE1 · UNKNOWN · sponsor: **African Malaria Network Trust** · enrollment: 45 (estimated)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** MSP 3 Long Synthetic Peptide
- **BIOLOGICAL:** Hepatitis B vaccine
- **BIOLOGICAL:** Hepatitis B control vaccince

## Key facts

- **NCT ID:** NCT00452088
- **Lead sponsor:** African Malaria Network Trust
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2008-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452088, "A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00452088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*